Use fundamental data analysis to double-check all available reported financial drivers of CVS Health to find out if markets are now mispricing the company. We found thirty-eight available fundamental indicators for CVS Health Corporation which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all CVS Health fundamentals including its Revenue, Cash Flow from Operations, Current Asset, as well as the relationship between Cash per Share and Beta . Given that CVS Health has Price to Earning of 14.30 times, we suggest you validate CVS Health Corporation prevailing market performance to make sure the company can sustain itself next year.Use CVS Health to protect against small markets fluctuations. The stock experiences somewhat bearish sentiment, but market may correct it shortly. Check odds of CVS Health to be traded at $68.38 in 30 days
CVS Health Valuation Over Time
CVS Health Company SummaryCVS Health competes with Laboratory of, MEDNAX, Envision Healthcare, Concord Medical, and CENTENE CORP. CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island. CVS Health operates under Healthcare Services classification in USA and traded on New York Stock Exchange exchange.
CVS Health Earnings Per Share vs Z Score
CVS Health Corporation is rated third in earnings per share category among related companies. It is rated fourth in z score category among related companies totaling about 0.45 of Z Score per Earnings Per Share. The ratio of Earnings Per Share to Z Score for CVS Health Corporation is roughly 2.20